Insider · CIK 0001701815

Aghazadeh Behzad

Reports to the SEC for 5 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001701815

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-28	SCTXScribe Therapeutics, Inc.P Purchase	Director, 10% Owner, See Remarks	PPurchase	+7,905 sh	$18.25	+$144K	3,088,888
2026-07-24	SCTXScribe Therapeutics, Inc.P Purchase	Director, 10% Owner, See Remarks	PPurchase	+2.33M sh	$15.00	+$35M	3,030,983
2026-07-24	SCTXScribe Therapeutics, Inc.P Purchase	Director, 10% Owner, See Remarks	PPurchase	+50K sh	$22.31	+$1.12M	3,080,983
2026-07-23	SCTXScribe Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner, See Remarks	AAward	+14.7K sh	—	—	14,725
2026-06-12	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+38K sh	—	—	38,040
2025-06-12	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+40K sh	—	—	40,006
2025-02-28	WHWKWhitehawk Therapeutics, Inc. · Pre-funded Warrant (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+8.33M sh	$2.40	+$20M	8,333,000
2024-06-12	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+45.8K sh	—	—	45,832
2023-06-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+28.3K sh	—	—	28,255
2022-09-22	WHWKWhitehawk Therapeutics, Inc.A Award	Director, 10% Owner, See remarks	AAward	+1.26M sh	$12.50	+$15.8M	3,471,752
2022-06-15	WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+18.6K sh	—	—	18,573
2021-08-27	WHWKWhitehawk Therapeutics, Inc. · Stock option (right to buy)A Award	Director, 10% Owner, See remarks	AAward	+17.5K sh	—	—	17,549
2021-08-26	WHWKWhitehawk Therapeutics, Inc.A Award	Director, 10% Owner, See remarks	AAward	+1.91M sh	$13.08	+$25M	2,211,752
2020-10-23	IMMUNOMEDICS INCD Disposition to Issuer	Director, 10% Owner, See Remarks	DDisposition to Issuer	−13.5K sh	—	—	0
2020-10-23	IMMUNOMEDICS INCStock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner, See Remarks	DDisposition to Issuer	−203K sh	—	—	0
2020-10-23	IMMUNOMEDICS INCRestricted Stock UnitD Disposition to Issuer	Director, 10% Owner, See Remarks	DDisposition to Issuer	−104K sh	—	—	0
2020-10-23	IMMUNOMEDICS INCD Disposition to Issuer	Director, 10% Owner, See Remarks	DDisposition to Issuer	−26.3M sh	—	—	0
2020-06-18	IMMUNOMEDICS INCStock Option (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+6,540 sh	—	—	6,540
2020-06-18	IMMUNOMEDICS INCA Award	Director, 10% Owner, See Remarks	AAward	+3,718 sh	—	—	17,234
2020-03-20	IMMUNOMEDICS INCA Award	Director, 10% Owner, See Remarks	AAward	+100K sh	—	—	100,000
2019-11-19	IMMUNOMEDICS INCStock Option (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+150K sh	—	—	150,000
2019-06-07	IMMUNOMEDICS INCA Award	Director, 10% Owner, See Remarks	AAward	+9,667 sh	—	—	13,516
2019-06-07	IMMUNOMEDICS INCStock Option (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+17.1K sh	—	—	17,077
2018-04-02	IMMUNOMEDICS INCA Award	Director, 10% Owner, See Remarks	AAward	+3,849 sh	—	—	3,849
2018-04-02	IMMUNOMEDICS INCStock Options (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+6,497 sh	—	—	6,497
2017-11-15	IMMUNOMEDICS INCP Purchase	Director, 10% Owner, See Remarks	PPurchase	+175K sh	$10.97	+$1.92M	16,064,461
2017-11-14	IMMUNOMEDICS INCP Purchase	Director, 10% Owner, See Remarks	PPurchase	+1.15M sh	$10.39	+$11.9M	15,889,461
2017-08-24	IMMUNOMEDICS INCSeries A-1 Convertible Preferred StockC Conversion	Director, 10% Owner, See Remarks	CConversion	−184K sh	—	—	0
2017-08-24	IMMUNOMEDICS INCC Conversion	Director, 10% Owner, See Remarks	CConversion	+4.25M sh	—	—	14,739,462
2017-08-23	IMMUNOMEDICS INCCall Option (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+1,250 sh	$3.24	+$4,046	8,750
2017-08-23	IMMUNOMEDICS INCPut Option (obligation to buy)S Sale	Director, 10% Owner, See Remarks	SSale	+1,250 sh	$0.76	+$950.625	8,750
2017-08-22	IMMUNOMEDICS INCCall Option (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+2,500 sh	$3.20	+$8,007.75	7,500
2017-08-22	IMMUNOMEDICS INCPut Option (obligation to buy)S Sale	Director, 10% Owner, See Remarks	SSale	+2,500 sh	$0.73	+$1,822.75	7,500
2017-08-21	IMMUNOMEDICS INCCall Option (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+5,000 sh	$2.84	+$14.2K	5,000
2017-08-21	IMMUNOMEDICS INCPut Option (obligation to buy)S Sale	Director, 10% Owner, See Remarks	SSale	+5,000 sh	$0.77	+$3,849.5	5,000
2017-07-03	IMMUNOMEDICS INCStock Options (right to buy)A Award	Director, 10% Owner, See Remarks	AAward	+22.5K sh	—	—	22,500
2017-05-04	IMMUNOMEDICS INCSeries A-1 Convertible Preferred Stock, par value $0.01A Award	Director, 10% Owner, See Remarks	AAward	+184K sh	$125.00	+$23M	184,000

Recent filings

Accepted (ET)
Jul 284
Avoro Capital Advisors LLC0000902664-26-003270
SEC(opens sec.gov)
Jul 274
Avoro Capital Advisors LLC0000902664-26-003254
SEC(opens sec.gov)
Jun 154
Avoro Capital Advisors LLC0001701815-26-000006
SEC(opens sec.gov)
Jun 164
Avoro Capital Advisors LLC0001415889-25-017406
SEC(opens sec.gov)
Mar 44
Avoro Capital Advisors LLC0000902664-25-001334
SEC(opens sec.gov)
Jun 144
Avoro Capital Advisors LLC0001415889-24-016874
SEC(opens sec.gov)
Jun 204
Avoro Capital Advisors LLC0001209191-23-038675
SEC(opens sec.gov)
Sep 264
Avoro Capital Advisors LLC0000902664-22-004356
SEC(opens sec.gov)
Jun 174
Avoro Capital Advisors LLC0001209191-22-037859
SEC(opens sec.gov)
Aug 304
Avoro Capital Advisors LLC0000902664-21-004071
SEC(opens sec.gov)
Oct 234
Aghazadeh Behzad0001104659-20-117806
SEC(opens sec.gov)
Jun 224
Aghazadeh Behzad0001104659-20-075724
SEC(opens sec.gov)
Mar 204
Avoro Capital Advisors LLC0001104659-20-037009
SEC(opens sec.gov)

Companies

Address

C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800

NEW YORK, NY, 10012